<DOC>
	<DOCNO>NCT00004153</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure may improve ability detect presence recurrence disease . PURPOSE : Diagnostic trial detect melanoma marker lymph nodes peripheral blood patient melanoma .</brief_summary>
	<brief_title>Detection Melanoma Markers Lymph Nodes Peripheral Blood Patients With Melanoma</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility perform reverse transcriptase-polymerase chain reaction ( RT-PCR ) five different tumor antigen gene use lymph node sample peripheral blood patient melanoma . - Determine ability PCR-positive lymph node peripheral blood predict relapse disease patient . - Determine correlation positive PCR result peripheral blood disease stage . OUTLINE : Lymph node biopsy peripheral blood obtain patient . These specimen examine nested reverse transcriptase-polymerase chain reaction ( RT-PCR ) analyze various tumor antigen . Patients may choose told result test , result influence change plan therapy . Brief counseling require discuss result potential implication . Patients follow least 2 year . PROJECTED ACCRUAL : A total 30 patient lymph node portion 80 patient ( 20 per stage disease ) peripheral blood portion accrue study within 3 year .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Clinically proven melanoma indication perform sentinel lymph node biopsy elective lymph node dissection OR Histologically proven diagnosis highly suspicious melanoma PATIENT CHARACTERISTICS : Age : Any age Performance status : Not specify Life expectancy : Not specify Hematopoietic : Platelet count great 50,000/mm^3 Hemoglobin great 7 g/dL Hepatic : PT le 15 sec PTT le 30 sec Renal : Not specify Other : No psychiatric illness precludes compliance No concurrent malignancy PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>stage I melanoma</keyword>
	<keyword>stage II melanoma</keyword>
	<keyword>stage III melanoma</keyword>
	<keyword>stage IV melanoma</keyword>
</DOC>